SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Alfacell (ACEL) -- Ignore unavailable to you. Want to Upgrade?


To: celeryroot.com who wrote (1471)7/16/1998 6:03:00 PM
From: Greg Kevorkian  Respond to of 1533
 
If anyone has the Ramsey report from 4/97 read about the Pancreatic P2 trial. Very interesting. The comparasion of Onconase P2 against Gemzar P3.
As I read it we failed in that study based on the population used. It is even shown the difference in patient level. BUT, when they went back and compared
similar patients we were GREATLY better. Was this the case now? Does anyone have a patient profile? Check it out and comment. Did they compare apples to apples.
I would be interested in any other interpretations.
G